IFNG and myeloid sarcoma: Among immune cells, CD4+ T cells are recognized as key players in MS pathogenesis (Høglund and Maghazachi, 2014[57]; Kasper and Shoemaker, 2010[65]), with prolonged release of interferon gamma (IFN-γ) contributing to inflammation (Vartanian et al., 1995[117]).